An arrhythmogenic metabolite in atrial fibrillation

被引：3

作者：

Krause, Julia ^{[1
,2
]}

Nickel, Alexander ^{[3
]}

Madsen, Alexandra ^{[2
,4
]}

Aitken-Buck, Hamish M. ^{[5
]}

Stoter, A. M. Stella ^{[2
,4
]}

Schrapers, Jessica ^{[2
,4
]}

Ojeda, Francisco ^{[6
]}

Geiger, Kira ^{[3
]}

Kern, Melanie ^{[3
]}

Kohlhaas, Michael ^{[3
]}

Bertero, Edoardo ^{[3
]}

Hofmockel, Patrick ^{[3
]}

Huebner, Florian ^{[7
]}

Assum, Ines ^{[8
,9
]}

Heinig, Matthias ^{[8
,9
]}

Mueller, Christian ^{[2
,6
]}

Hansen, Arne ^{[2
,4
]}

Krause, Tobias ^{[2
,4
]}

Park, Deung-Dae ^{[10
]}

Just, Steffen ^{[10
]}

Aissi, Dylan ^{[6
]}

Boernigen, Daniela ^{[6
]}

Lindner, Diana ^{[2
,6
,22
]}

Friedrich, Nele ^{[11
,12
]}

Alhussini, Khaled ^{[13
]}

Bening, Constanze ^{[13
]}

Schnabel, Renate B. ^{[2
,6
]}

Karakas, Mahir ^{[2
,14
]}

Iacoviello, Licia ^{[15
,16
]}

Salomaa, Veikko ^{[17
]}

Linneberg, Allan ^{[18
,19
]}

Tunstall-Pedoe, Hugh ^{[20
]}

Kuulasmaa, Kari ^{[17
]}

Kirchhof, Paulus ^{[2
,6
,21
]}

Blankenberg, Stefan ^{[2
,6
]}

Christ, Torsten ^{[2
,4
]}

Eschenhagen, Thomas ^{[2
,4
]}

Lamberts, Regis R. ^{[5
]}

Maack, Christoph ^{[3
]}

Stenzig, Justus ^{[2
,4
]}

Zeller, Tanja ^{[1
,2
]}

机构：

[1] Univ Med Ctr Hamburg Eppendorf, Univ Ctr Cardiovasc Sci, Univ Heart & Vasc Ctr Hamburg, Dept Cardiol, Martinistr 52, D-20246 Hamburg, Germany

[2] DZHK German Ctr Cardiovasc Res, Partner Site Hamburg Kiel Lubeck, Hamburg, Germany

[3] Univ Clin Wurzburg, Comprehens Heart Failure Ctr, Wurzburg, Germany

[4] Univ Med Ctr Hamburg Eppendorf, Inst Expt Pharmacol & Toxicol, Hamburg, Germany

[5] Univ Otago, Sch Biomed Sci, Dept Physiol, HeartOtago, Dunedin, New Zealand

[6] Univ Heart & Vasc Ctr Hamburg, Dept Cardiol, Hamburg, Germany

[7] Univ Munster, Inst Food Chem, Munster, Germany

[8] Helmholtz Zentrum Munchen, Inst Computat Biol, Munich, Germany

[9] Tech Univ Munich, Dept Informat, Munich, Germany

[10] Univ Ulm, Dept Internal Med 2, Mol Cardiol, Ulm, Germany

[11] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany

[12] DZHK German Ctr Cardiovasc Res, Partner Site Greifswald, Greifswald, Germany

[13] Univ Clin Wurzburg, Dept Thorac & Cardiovasc Surg, Wurzburg, Germany

[14] Univ Med Ctr Hamburg Eppendorf, Dept Intens Care Med, Hamburg, Germany

[15] IRCCS Neuromed, Dept Epidemiol & Prevent, Pozzilli, Italy

[16] Univ Insubria, Res Ctr Epidemiol & Prevent Med EPIMED, Dept Med & Surg, Varese, Italy

[17] Finnish Inst Hlth & Welf, Helsinki, Finland

[18] Bispebjerg & Frederiksberg Hosp, Ctr Clin Res & Prevent, Capital Reg Denmark, Copenhagen, Denmark

[19] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark

[20] Univ Dundee, Inst Cardiovasc Res, Cardiovasc Epidemiol Unit, Dundee, Scotland

[21] Univ Birmingham, Inst Cardiovasc Sci, Birmingham, England

[22] Univ Freiburg, Univ Heart Ctr Freiburg Bad Krozingen, Dept Cardiol & Angiol, Fac Med,Med Ctr, D-79106 Freiburg, Germany

来源：

JOURNAL OF TRANSLATIONAL MEDICINE | 2023年 / 21卷 / 01期

基金：

欧洲研究理事会;

关键词：

Metabolites; Acyl-carnitine; Atrial fibrillation; Translational medicine; Engineered heart tissue; LONG-CHAIN ACYLCARNITINES; FATTY-ACID OXIDATION; HEART; MITOCHONDRIAL; CALCIUM; CARDIOMYOCYTES; MYOCARDIUM; TISSUE; LEAK;

D O I：

10.1186/s12967-023-04420-z

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Background Long-chain acyl-carnitines (ACs) are potential arrhythmogenic metabolites. Their role in atrial fibrillation (AF) remains incompletely understood. Using a systems medicine approach, we assessed the contribution of C18:1AC to AF by analysing its in vitro effects on cardiac electrophysiology and metabolism, and translated our findings into the human setting.Methods and results Human iPSC-derived engineered heart tissue was exposed to C18:1AC. A biphasic effect on contractile force was observed: short exposure enhanced contractile force, but elicited spontaneous contractions and impaired Ca2+ handling. Continuous exposure provoked an impairment of contractile force. In human atrial mitochondria from AF individuals, C18:1AC inhibited respiration. In a population-based cohort as well as a cohort of patients, high C18:1AC serum concentrations were associated with the incidence and prevalence of AF.Conclusion Our data provide evidence for an arrhythmogenic potential of the metabolite C18:1AC. The metabolite interferes with mitochondrial metabolism, thereby contributing to contractile dysfunction and shows predictive potential as novel circulating biomarker for risk of AF.

引用

页数：16

共 50 条

[21] Adenosine-induced atrial fibrillation arising from arrhythmogenic right atrial appendage
Ishihara, Takeshi
Takasugi, Nobuhiro
Naruse, Genki
Okura, Hiroyuki
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2020, 31 (01) : 234 - 235
[22] Bigeminal potentials in the pulmonary vein indicate arrhythmogenic trigger of atrial fibrillation
Mukai, Yasushi
Kawai, Shunsuke
Inoue, Shujiro
Takase, Susumu
Sakamoto, Kazuo
Nagaoka, Kazuhiro
Chishaki, Akiko
Tsutsui, Hiroyuki
JOURNAL OF ARRHYTHMIA, 2021, 37 (02) : 331 - 337
[23] Induction of heat shock proteins prevents the arrhythmogenic substrate for atrial fibrillation
Takahashi, Naohiko
Wakisaka, O.
Yoshimatsu, H.
Saikawa, T.
INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2009, 25 (08) : 641 - 646
[24] The Clinical Role of Atrial Fibrillation in Patients with Arrhythmogenic Right Ventricular Dysplasia
Saguner, Ardan M.
Baldinger, Samuel
Medeiros-Domingo, Argelia
Ganahl, Sabrina
Tanner, Felix C.
Brunckhorst, Corinna
Duru, Firat
CIRCULATION, 2014, 130
[25] Electrophysiological and arrhythmogenic effects of 5-hydroxytryptamine on human atrial cells are reduced in atrial fibrillation
Pau, Davide
Workman, Antony J.
Kane, Kathleen A.
Rankin, Andrew C.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2007, 42 (01) : 54 - 62
[26] Influences of Autonomic Nervous System on Atrial Arrhythmogenic Substrates and the Incidence of Atrial Fibrillation in Diabetic Heart
Otake, Hideki
Suzuki, Hitoshi
Honda, Takashi
Maruyama, Yukio
INTERNATIONAL HEART JOURNAL, 2009, 50 (05) : 627 - 641
[27] Relationship Between Arrhythmogenic Pulmonary Veins and the Surrounding Atrial Substrate in Patients with Paroxysmal Atrial Fibrillation
Suenari, Kazuyoshi
Lin, Yenn-Jiang
Chang, Shih-Lin
Lo, Li-Wei
Hu, Yu-Feng
Tuan, Ta-Chuan
Huang, Shih-Yu
Tai, Ching-Tai
Nakano, Yukiko
Kihara, Yasuki
Tsao, Hsuan-Ming
Wu, Tsu-Juey
Chen, Shih-Ann
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2011, 22 (04) : 405 - 410
[28] Alterations in the expression of atrial calpains in electrical and structural remodeling during aging and atrial fibrillation
Xu, Guo-Jun
Gan, Tian-Yi
Tang, Bao-Peng
Chen, Zu-Heng
Mahemuti, Ailiman
Jiang, Tao
Song, Jian-Guo
Guo, Xia
Li, Yao-Dong
Zhou, Xian-Hui
Zhang, Yu
Li, Jin-Xin
MOLECULAR MEDICINE REPORTS, 2013, 8 (05) : 1343 - 1352
[29] Clinical Impact of Adenosine Triphosphate Injection on Arrhythmogenic Superior Vena Cava in the Context of Atrial Fibrillation Ablation
Miyazaki, Shinsuke
Taniguchi, Hiroshi
Komatsu, Yuki
Uchiyama, Takashi
Kusa, Shigeki
Nakamura, Hiroaki
Hachiya, Hitoshi
Hirao, Kenzo
Iesaka, Yoshito
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2013, 6 (03) : 497 - 503
[30] QUest for the Arrhythmogenic Substrate of Atrial fibRillation in Patients Undergoing Cardiac Surgery (QUASAR Study): Rationale and Design
van der Does, Lisette J. M. E.
Yaksh, Ameeta
Kik, Charles
Knops, Paul
Lanters, Eva A. H.
Teuwen, Christophe P.
Oei, Frans B. S.
van de Woestijne, Pieter C.
Bekkers, Jos A.
Bogers, Ad J. J. C.
Allessie, Maurits A.
de Groot, Natasja M. S.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2016, 9 (03) : 194 - 201

← 1 2 3 4 5 →